Differential tyrosine phosphorylation of leukemic cells during apoptosis as a result of treatment with imatinib mesylate

Biochemical and Biophysical Research Communications

Volumn 336, Issue 3, 2005, Pages 942-951

  Park, Jungeun ^a   Kim, Sangmi ^a   Oh, Chongkil ^a   Sung, Soo Yoon ^a   Lee, Dongsoon ^a   Kim, Youngsoo ^a  

^a Seoul National University   (South Korea)

Author keywords

Chronic myelogenous leukemia; Imatinib mesylate; Proteomics; Two dimensional gel electrophoresis; Tyrosine phosphorylation

Indexed keywords

BCR ABL PROTEIN; HYBRID PROTEIN; IMATINIB; PROTEIN TYROSINE KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL POPULATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DATA ANALYSIS; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FUSION PROTEINS, BCR-ABL; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; PHOSPHORYLATION; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTEOME; PYRIMIDINES; TRANSCRIPTION, GENETIC; TYROSINE;

EID: 25144442282     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.201     Document Type: Article

References (40)

1. B.J. Druker, S.G. O'Brien, J. Cortes, and J. Radich Chronic myelogenous leukemia Hematology 2002 111 135
2. M. Warmuth, S. Danhauser-Riedl, and M. Hallek Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies Ann. Hematol. 78 1999 49 64
3. M.G. Kharas, and D.A. Fruman ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors Cancer Res. 65 2005 2047 2053
4. R. Arlinghaus, and T. Sun Signal transduction pathways in Bcr-Abl transformed cells Cancer Treat Res. 119 2004 239 270
5. N. Cambier, R. Chopra, A. Strasser, D. Metcalf, and A.G. Elefanty BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner Oncogene 16 1998 335 348
6. I.R. Radford Imatinib. Novartis Curr. Opin. Inves. Drugs 3 2002 492 499
7. L. Puil, J. Liu, G. Gish, G. Mbamalu, D. Bowtell, P.G. Pelicci, R. Arlinghaus, and T. Pawson Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway EMBO J. 13 1994 764 773
8. S. Li, A.D. Couvillon, B.B. Brasher, and R.A. Van Etten Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling EMBO J. 20 2001 6793 6804
9. D. Cortez, L. Kadlec, and A.M. Pendergast Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis Mol. Cell. Biol. 15 1995 5531 5541
10. G. Fang, C.N. Kim, C.L. Perkins, N. Ramadevi, E. Winton, S. Wittmann, and K.N. Bhalla CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs Blood 96 2000 2246 2253
11. S. Fernandez de Mattos, A. Essafi, I. Soeiro, A.M. Pietersen, K.U. Birkenkamp, C.S. Edwards, A. Martino, B.H. Nelson, J.M. Francis, M.C. Jones, J.J. Brosens, P.J. Coffer, and E.W. Lam FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism Mol. Cell. Biol. 24 2004 10058 10071
12. Y. Parada, L. Banerji, J. Glassford, N.C. Lea, M. Collado, C. Rivas, J.L. Lewis, M.Y. Gordon, N.S. Thomas, and E.W. Lam BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression J. Biol. Chem. 276 2001 23572 23580
13. A.L. Gartel, and K. Shchors Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes Exp. Cell Res. 283 2003 17 21
14. K.H. Vousden Switching from life to death: the Miz-ing link between Myc and p53 Cancer Cell 2 2002 351 352
15. G. Brumatti, R. Weinlich, C.F. Chehab, M. Yon, and G.P. Amarante-Mendes Comparison of the anti-apoptotic effects of Bcr-Abl, Bcl-2 and Bcl-x(L) following diverse apoptogenic stimuli FEBS Lett. 541 2003 57 63
16. F. Gesbert, and J.D. Griffin Bcr/Abl activates transcription of the Bcl-X gene through STAT5 Blood 96 2000 2269 2276
17. G.P. Amarante-Mendes, A.J. McGahon, W.K. Nishioka, D.E. Afar, O.N. Witte, and D.R. Green Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL Oncogene 16 1998 1383 1390
18. H.C. Chen, W.C. Lin, Y.G. Tsay, S.C. Lee, and C.J. Chang An RNA helicase, DDX1, interacting with poly(A) RNA and heterogeneous nuclear ribonucleoprotein K J. Biol. Chem. 277 2002 40403 40409
19. K.N. Mahajan, and B.S. Mitchell Role of human Pso4 in mammalian DNA repair and association with terminal deoxynucleotidyl transferase Proc. Natl. Acad. Sci. USA 100 2003 10746 10751
20. W. Freist, D.T. Logan, and D.H. Gauss Glycyl-tRNA synthetase Biol. Chem. Hoppe. Seyler. 377 1996 343 356
21. G. Fusaro, P. Dasgupta, S. Rastogi, B. Joshi, and S. Chellappan Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling J. Biol. Chem. 278 2003 47853 47861
22. T. Yokogawa, N. Shimada, N. Takeuchi, L. Benkowski, T. Suzuki, A. Omori, T. Ueda, K. Nishikawa, L.L. Spremulli, and K. Watanabe Characterization and tRNA recognition of mammalian mitochondrial seryl-tRNA synthetase J. Biol. Chem. 275 2000 19913 19920
23. S. Yokota, H. Yanagi, T. Yura, and H. Kubota Cytosolic chaperonin is up-regulated during cell growth. Preferential expression and binding to tubulin at G(1)/S transition through early S phase J. Biol. Chem. 274 1999 37070 37078
24. S.E. Babbitt, A. Kiss, A.E. Deffenbaugh, Y.H. Chang, E. Bailly, H. Erdjument-Bromage, P. Tempst, T. Buranda, L.A. Sklar, J. Baumler, E. Gogol, and D. Skowyra ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle Cell 121 2005 553 565
25. M.K. London, B.I. Keck, P.C. Ramos, and R.J. Dohmen Regulatory mechanisms controlling biogenesis of ubiquitin and the proteasome FEBS Lett. 567 2004 259 264
26. D.M. Ferrari, P. Nguyen Van, H.D. Kratzin, and H.D. Soling ERp28, a human endoplasmic-reticulum-lumenal protein is a member of the protein, disulfide isomerase family but lacks a CXXC thioredoxin-box motif Eur. J. Biochem. 255 1998 570 579
27. R. Tian, S.J. Li, D.L. Wang, Z. Zhao, Y. Liu, and R.Q. He The acidic C-terminal domain stabilizes the chaperone function of protein disulfide isomerase J. Biol. Chem. 279 2004 48830 48835
28. D. Kloor, and H. Osswald S-Adenosylhomocysteine hydrolase as a target for intracellular adenosine action Trends Pharmacol. Sci. 25 2004 294 297
29. B.W. Shen, M. Hennig, E. Hohenester, J.N. Jansonius, and T. Schirmer Crystal structure of human recombinant ornithine aminotransferase J. Mol. Biol. 277 1998 81 102
30. T. Kawano, J. Horiguchi-Yamada, S. Saito, S. Iwase, Y. Furukawa, Y. Kano, and H. Yamada Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells Leuk. Res. 28 2004 623 629
31. K. Kuzelova, D. Grebenova, I. Marinov, and Z. Hrkal Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells J. Cell Biochem. 95 2005 268 280
32. M. Canelles, M.D. Delgado, K.M. Hyland, A. Lerga, C. Richard, C.V. Dang, and J. Leon Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells Oncogene 14 1997 1315 1327
33. A. Ciechanover, A. Orian, and A.L. Schwartz Ubiquitin-mediated proteolysis: biological regulation via destruction Bioessays 22 2000 442 451
34. M. Orlowski, and S. Wilk Ubiquitin-independent proteolytic functions of the proteasome Arch. Biochem. Biophys. 415 2003 1 5
35. T. Wang The 26S proteasome system in the signaling pathways of TGF-beta superfamily Front Biosci. 8 2003 1109 1127
36. R.D. Unwin, D.W. Sternberg, Y. Lu, A. Pierce, D.G. Gilliland, and A.D. Whetton Global effects of BCR/ABL and TEL/PDGFRbeta expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR/ABL J. Biol. Chem. 280 2005 6316 6326
37. Y.P. Lim, C.Y. Wong, L.L. Ooi, B.J. Druker, and R.J. Epstein Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugs Clin. Cancer Res. 10 2004 3980 3987
38. T. Higuchi, Y. Watanabe, and I. Waga Protein disulfide isomerase suppresses the transcriptional activity of NF-kappaB Biochem. Biophys. Res. Commun. 318 2004 46 52
39. S. Pfeffer, and D. Aivazian Targeting Rab GTPases to distinct membrane compartments Nat. Rev. Mol. Cell Biol. 5 2004 886 896
40. C. DerMardirossian, A. Schnelzer, and G.M. Bokoch Phosphorylation of RhoGDI by Pak1 mediates dissociation of Rac GTPase Mol. Cell 15 2004 117 127